New imaging technologies, digital platforms, AI systems, and groundbreaking radiopharmaceuticals are reshaping diagnostics ...
California clinics' doors are flying open, patients are lining up and ketamine is being prescribed off-label for everything ...
A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.
Resistant hypertension remains a tough adversary in the fight against the global rise of cardiovascular disease, but updated guidance, new tools and new drugs on the horizon provide hope.Hypertension ...
Qihan's QT-019B program is supported by IND clearance for rSLE from both the US FDA and the China NMPA. The FDA has also granted Fast Track Designation for the SLE-ITP indication. Phase 1 enrollment ...
Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients ...
Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a ...
Research presented at the 2025 ASH Annual Meeting sheds light on serious side effects that appear weeks or months after CAR T cell therapy for multiple myeloma.
Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, ...
Everyday Health on MSN
40 wellness gifts for loved ones with OCD, recommended by a therapist who gets it
Discover 40 soothing wellness gifts for people with OCD. See therapist-recommended mindfulness gifts that go beyond the ...
Presented in an oral session at the 67th American Society of Hematology Annual Meeting & Exposition ...
InvestorsHub on MSN
Cogent Biosciences jumps after strong late-stage results in advanced systemic mastocytosis
Cogent Biosciences Inc. (NASDAQ:COGT) surged 12.6% in Monday’s premarket session after unveiling encouraging top-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results